## Clinical Diagnosis: Constitutional Delay of Puberty with Delayed Menarche ### Key Features in This Case **Key Point:** This patient has normal secondary sexual characteristics (Tanner stage 5 breast and pubic hair development) with normal pelvic ultrasound and normal hormonal profile — the hallmark of constitutional delay of menarche. ### Differential Diagnosis Approach | Feature | Constitutional Delay | Müllerian Agenesis | Hypothyroidism | Hyperprolactinemia | |---------|---------------------|-------------------|-----------------|-------------------| | **Secondary sexual characteristics** | Normal | Normal | Delayed/absent | Normal | | **Uterus on ultrasound** | Present | Absent | Present | Present | | **FSH/LH** | Normal | Normal/high | Low | Low | | **Prolactin** | Normal | Normal | Normal | Elevated | | **TSH** | Normal | Normal | Elevated | Normal | | **Age at presentation** | 14–16 years | Any age | Variable | Variable | ### Why Constitutional Delay? 1. **Normal pubertal development:** Tanner stage 5 breast and pubic hair indicates complete secondary sexual development, which excludes true hypogonadism. 2. **Normal hormonal profile:** FSH, LH, prolactin, and thyroid function are all normal — rules out endocrine pathology. 3. **Normal pelvic anatomy:** Uterus and ovaries are present and morphologically normal — excludes Müllerian agenesis. 4. **Age and presentation:** At 16 years, this is within the upper limit of normal variation for menarche in healthy adolescents; some girls menstruate as late as 16–17 years without pathology. **High-Yield:** Constitutional delay of menarche is a diagnosis of exclusion in a girl with normal secondary sexual characteristics, normal anatomy, and normal hormones. It requires reassurance and follow-up; menarche typically occurs within 6–12 months. **Clinical Pearl:** The presence of normal breast and pubic hair development (indicating adequate estrogen and adrenal androgens) with normal FSH/LH makes primary hypogonadism extremely unlikely. The normal prolactin excludes hyperprolactinemia-induced amenorrhea. ### Management - Reassurance and counseling about normal variation in timing of menarche. - Repeat evaluation in 6–12 months if menarche has not occurred. - No hormonal intervention is required unless menarche is delayed beyond age 17–18 years.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.